Anhui Provincial Hospital

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Liver and biliary tract cancer2 trials
• Gastric and oesophageal cancer1 trial

Phase

• Phase 33 trials

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Hoffmann-La Roche3 trials

Running trials

• Active, not recruiting

  A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma

  NCT04712643· Phase 3· Hoffmann-La Roche· Source

Closed trials

• Completed

  A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma

  NCT04540211· Phase 3· Hoffmann-La Roche· Source

• Completed

  A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation

  NCT04102098· Phase 3· Hoffmann-La Roche· Source